QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 164 filers reported holding QIAGEN NV in Q4 2013. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,625,000 | -8.9% | 165,076 | -10.8% | 0.04% | -5.4% |
Q3 2016 | $5,075,000 | +42.8% | 184,966 | +13.5% | 0.04% | +32.1% |
Q2 2016 | $3,555,000 | -38.3% | 162,993 | -36.8% | 0.03% | -42.9% |
Q1 2016 | $5,758,000 | -17.6% | 257,759 | +2.0% | 0.05% | -23.4% |
Q4 2015 | $6,985,000 | +14.4% | 252,627 | +6.7% | 0.06% | +3.2% |
Q3 2015 | $6,108,000 | +12.7% | 236,731 | +8.3% | 0.06% | +10.7% |
Q2 2015 | $5,419,000 | +10.4% | 218,601 | +12.2% | 0.06% | +1.8% |
Q1 2015 | $4,908,000 | +24.8% | 194,776 | +16.2% | 0.06% | +14.6% |
Q4 2014 | $3,932,000 | -8.6% | 167,591 | -11.2% | 0.05% | -17.2% |
Q3 2014 | $4,300,000 | +16.0% | 188,832 | +24.5% | 0.06% | +7.4% |
Q2 2014 | $3,708,000 | +14.6% | 151,670 | -1.1% | 0.05% | +20.0% |
Q1 2014 | $3,236,000 | -0.1% | 153,416 | +12.8% | 0.04% | -10.0% |
Q4 2013 | $3,238,000 | +70.5% | 136,013 | +53.2% | 0.05% | +35.1% |
Q3 2013 | $1,899,000 | +25.5% | 88,757 | +16.8% | 0.04% | +2.8% |
Q2 2013 | $1,513,000 | – | 76,014 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Exane Asset Management | 642,752 | $14,260,214,000 | 5.53% |
Tikvah Management LLC | 369,425 | $8,057,000 | 4.72% |
Hardman Johnston Global Advisors LLC | 3,797,024 | $82,813,000 | 4.22% |
HealthCor Management, L.P. | 2,500,000 | $54,525,000 | 2.97% |
Opus Point Partners Management, LLC | 105,751 | $2,306,000 | 2.23% |
CRAMER ROSENTHAL MCGLYNN LLC | 4,018,074 | $87,634,000 | 1.41% |
Douglas Lane & Associates, LLC | 1,942,678 | $42,370,000 | 1.22% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,167,768 | $47,279,000 | 1.17% |
MANNING & NAPIER ADVISORS LLC | 6,111,364 | $133,287,000 | 0.81% |
PRIMECAP MANAGEMENT CO/CA/ | 20,128,325 | $438,999,000 | 0.47% |